Upstream Bio (UPB) Return on Capital Employed (2024 - 2026)

Upstream Bio's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 53.36% for Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 3274.0% year-over-year to 53.36% in Q1 2026; TTM through Mar 2026 was 53.36%, a 3274.0% decrease from a year earlier, with the FY2025 full-year figure at 39.66%, down 1273.0% from the prior year.
• Return on Capital Employed fell to 53.36% in Q1 2026 per UPB's latest filing, from 44.66% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 20.63% in Q1 2025 and bottomed at 53.36% in Q1 2026.
• The 3-year median for Return on Capital Employed is 32.06% (2025), against an average of 34.2%.
• Across the five-year window, Return on Capital Employed slumped 2222 bps in 2025 and tumbled 3274 bps in 2026, its largest moves.
• Year by year, Return on Capital Employed stood at 22.44% in 2024, then plunged by 99 bps to 44.66% in 2025, then declined by 19 bps to 53.36% in 2026.
• Per Business Quant, the three latest UPB Return on Capital Employed figures stand at 53.36% (Q1 2026), 44.66% (Q4 2025), and 35.67% (Q3 2025).